🟢 Context Therapeutics is trading 5.5% up today, extending a multi-day rebound

Context Therapeutics is trading 5.5% up today at $0.69, extending a multi-day rebound from last week’s lows.

• The move appears to be follow-through price action and bargain-hunting after prior volatility, as there are no fresh company-specific headlines driving the action today.
• Recent news is limited to a routine July 10 inducement stock option grant for a new employee, which market sources do not cite as a catalyst for the current move.
• The stock's upward momentum comes despite a broader downturn in the biotech sector, suggesting localized buying interest.